News + Filings Transactions
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
|
|
Kruger Kurt H
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 08/04/2022 |
4
| Kruger Kurt H (Director) has filed a Form 4 on Qualigen Therapeutics, Inc.|
Txns:
| Granted 40,000 options to buy
@ $0.5136, valued at
$20.5k
|
|
| 08/20/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 12/30/2020 |
4
| Kruger Kurt H (Director) has filed a Form 4 on Qualigen Therapeutics, Inc.|
Txns:
| Bought 4,000 shares
@ $2.935, valued at
$11.7k
|
|
| 11/23/2020 |
4
| Kruger Kurt H (Director) has filed a Form 4 on Qualigen Therapeutics, Inc.|
Txns:
| Bought 1,400 shares
@ $3.549, valued at
$5k
Bought 4,600 shares
@ $3.462, valued at
$15.9k
|
|
| 06/08/2020 |
4
| Kruger Kurt H (Director) has filed a Form 4 on Qualigen Therapeutics, Inc.|
Txns:
| Granted 50,000 options to buy
@ $5.13, valued at
$256.5k
|
|
| 05/27/2020 |
4
| Kruger Kurt H (Director) has filed a Form 4 on Qualigen Therapeutics, Inc.|
Txns:
| Acquired 8,857 options to buy
@ $2.5405, valued at
$22.5k
|
|
| 05/27/2020 |
3
| Kruger Kurt H (Director) has filed a Form 3 on Qualigen Therapeutics, Inc. |
| 08/16/2018 |
4
| Kruger Kurt H (CFO) has filed a Form 4 on EMMAUS LIFE SCIENCES, INC.|
Txns:
| Granted 50,000 options
@ $11.3, valued at
$565k
|
|
| 07/26/2018 |
3
| Kruger Kurt H (CFO) has filed a Form 3 on EMMAUS LIFE SCIENCES, INC. |
|
|